When was Dr. Reddy's in Netherlands founded?

Dr. Reddy's in Netherlands was founded in 1984.

Where is Dr. Reddy's in Netherlands located?

Dr. Reddy's in Netherlands is headquartered in Netherlands.

Where does Dr. Reddy's in Netherlands rank among its competitors?

Dr. Reddy's in Netherlands ranks 743rd amongst 1895 active competitors, of which 98 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was AstraZeneca, which secured $6.05M in Jul, 2025.

Who are the top competitors of Dr. Reddy's in Netherlands?

Dr. Reddy's in Netherlands' top competitors include AbbVie, Gilead and Amgen. Among them, AstraZeneca secured the most recent funding round in July, 2025.

Dr. Reddy's in Netherlands - 2026 Company Profile & Competitors

Company Details

Manufacturer of pharmaceutical products for the treatment of various diseases. This entity produces medications to address health conditions and manages the distribution of these treatments to healthcare providers and institutions. The business focuses on the development and supply of medicinal formulations to support patient care.

Website: drreddys.nl
Social
Part Of

Key Metrics

Founded Year

1984

Location

Netherlands

Stage

Public

Ranked

743^rd among 1895 active competitors

Similar Companies

AbbVie & 1923 more

Exit Details

Public

View Dr. Reddy's in Netherlands' full profile

Dr. Reddy's in Netherlands has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Dr. Reddy's in Netherlands include AbbVie, Gilead and Amgen. Here is the list of Top 10 competitors of Dr. Reddy's in Netherlands, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AbbVie 2012, Chicago (United States), Public	Research-based biopharmaceutical company	$14.7B	Berkshire Hathaway, Alcor Fund & 10 others	83/100
2nd	Gilead 1987, Foster City (United States), Acquired	Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others	-	BB Biotech, Jindal Ventures & 17 others	81/100
3rd	Amgen 1980, Thousand Oaks (United States), Public	Developer of pharmaceutical products for treating multiple diseases	-	Digital Pharma Lab, Amgen Business Development ... & 11 others	79/100
4th	AstraZeneca 1999, Cambridge (United Kingdom), Public	Developer of pharmaceutical medicines for oncology and various chronic diseases	-	Digital Pharma Lab, Columbia Capital & 13 others	76/100
5th	Lilly 1876, Indianapolis (United States), Public	Developer of traditional pharmaceutical medicines	-	Alcor Fund, Digital Pharma Lab & 11 others	75/100
6th	Johnson & Johnson 1886, New Brunswick (United States), Public	Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products	-	Western Technology Investment, Alcor Fund ... & 16 others	74/100
7th	Roivant Sciences 2014, New York City (United States), Public	Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases	$1.3B	SoftBank Vision Fund, NovaQuest Capital Management ... & 8 others	71/100
8th	Novartis 1996, Basel (Switzerland), Acquired	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Digital Pharma Lab, Atlas Venture & 9 others	71/100
9th	Roche 1896, Basel (Switzerland), Public	Developer of pharmaceuticals and diagnostics kits	-	Gilde Healthcare, SoftBank Group & 11 others	70/100
10th	Genentech 1976, San Francisco (United States), Acquired	R&D company focused on manufacturing drugs for multiple therapeutic areas	$72.5M	Ignite 500, The Column Group & 4 others	68/100
743rd	Dr. Reddy's in Netherlands 1984, Netherlands, Public	Manufacturer of pharmaceutical products for the treatment of various diseases	-	-	20/100